Wang David 4
4 · RESPONSE BIOMEDICAL CORP · Filed Apr 4, 2012
Insider Transaction Report
Form 4
Wang David
Director
Transactions
- Award
Stock Option (Right to Buy)
2012-04-02+400,000→ 400,000 totalExercise: $0.11Exp: 2022-04-02→ Common Stock (400,000 underlying)
Footnotes (3)
- [F1]Exercise prices shown are denominated in Canadian Dollars.
- [F2]100% of the options vest fully on the date which is one year after the date of grant.
- [F3]The options granted are subject to approval of shareholders and the Toronto Stock Exchange. If such approvals are not obtained, the options will expire.